SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-212321
Filing Date
2010-09-17
Accepted
2010-09-17 17:00:54
Documents
6
Period of Report
2010-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 29534
2 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION dex31.htm EX-3.1 5792
3 CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN dex101.htm EX-10.1 88060
4 PRESS RELEASE dex991.htm EX-99.1 7630
5 GRAPHIC g100470g48i23.jpg GRAPHIC 2022
6 GRAPHIC g100470g89m94.jpg GRAPHIC 5002
  Complete submission text file 0001193125-10-212321.txt   142832
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 101078749
SIC: 2834 Pharmaceutical Preparations